BRITNEY PETTIGREW

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner DENVER, NC NPI 1770109985

General Payments — all program years on this page

$585.41

  • Category: General Payments
  • Program years: PY2022–2023
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $403.96 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $403.9622

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $181.454
2023 $403.9622

Records — PY2023 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1002560147 Novo Nordisk Inc $9.55 02/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560159 Novo Nordisk Inc $11.94 07/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560171 Novo Nordisk Inc $15.94 09/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560183 Novo Nordisk Inc $17.53 10/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560195 Novo Nordisk Inc $17.56 01/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560207 Novo Nordisk Inc $17.86 05/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560219 Novo Nordisk Inc $18.21 01/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560229 Novo Nordisk Inc $18.63 04/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560241 Novo Nordisk Inc $19.72 02/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560253 Novo Nordisk Inc $20.98 03/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002560265 Novo Nordisk Inc $21.25 06/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1004360975 GlaxoSmithKline, LLC. $16.93 10/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026334161 Medtronic, Inc. $15.99 02/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1026854825 Exact Sciences Corporation $17.59 02/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1035802251 Cranial Technologies, Inc $19.35 06/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1046897623 Organon LLC $17.86 08/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049330583 PFIZER INC. $16.89 05/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049583621 PFIZER INC. $24.90 02/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050470637 SANOFI-AVENTIS U.S. LLC $19.84 04/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1054827799 Dexcom, Inc. $25.96 05/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056529915 Xeris Pharmaceuticals, Inc. $19.82 05/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
984533411 Neos Therapeutics, LP $19.66 07/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.